Anesthesia type during TAVI was not independently associated with mortality or MACCE after adjusting for baseline differences, despite an initial unadjusted advantage for local anesthesia (WR 1.79).
Does local anesthesia or conscious sedation improve mortality and MACCE compared to general anesthesia in patients undergoing transfemoral TAVI?
Patients undergoing transfemoral transcatheter aortic valve implantation (TAVI)
Local anesthesia or conscious sedation
General anesthesia
Hierarchical win-ratio prioritizing mortality over major adverse cardiovascular and cerebrovascular events (MACCE)composite
Apparent survival benefits of local anesthesia over general anesthesia in transfemoral TAVI are likely driven by baseline patient risk profiles rather than a causal effect of the anesthesia strategy.
Tasa de eventos absoluta: 0% vs 0%
Background: The optimal anesthesia strategy for transfemoral transcatheter aortic valve implantation (TAVI) remains uncertain. We evaluated the impact of local anesthesia, conscious sedation, and general anesthesia on early and long-term outcomes after TAVI. Methods: This single-center cohort included 401 patients undergoing transfemoral TAVI with local anesthesia (LA, n = 77), conscious sedation (CS, n = 147), or general anesthesia (GA, n = 177). Outcomes were assessed using hierarchical win-ratio analysis prioritizing mortality over major adverse cardiovascular and cerebrovascular events (MACCE), supported by Kaplan–Meier and restricted mean survival time analyses. Sensitivity analyses using inverse probability of treatment weighting (IPTW) were performed to account for baseline differences between groups. Results: Baseline comorbidities were broadly comparable, although GA patients had higher-risk anatomical and procedural features. In unadjusted win-ratio analyses, LA showed a significant advantage over GA at 0–6 months (win ratio WR 1.79; 95% CI 1.10–2.93; p = 0.020). After multivariable adjustment, LA remained superior to GA at 6–12 and 12–24 months (adjusted WR 1.67 and 1.56, both p < 0.05). One-year mortality differed significantly among groups (p = 0.012). RMST analysis demonstrated a cumulative survival advantage for LA versus GA, reaching 6.6 months at 60 months. MACCE-free survival was largely comparable across strategies. However, in IPTW-weighted analyses, anesthesia type was not independently associated with mortality or MACCE. Conclusions: Minimally invasive anesthesia strategies were associated with more favorable early survival patterns after transfemoral TAVI in primary analyses. However, after adjustment for baseline differences using IPTW, anesthesia type was not independently associated with mortality or MACCE. These findings suggest that apparent outcome differences may partly reflect underlying patient risk profiles rather than a purely causal effect of anesthesia strategy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Tuncay Kiris
Izmir Kâtip Çelebi University
Fatma Esin
Izmir Kâtip Çelebi University
Hakan Bozkurt
Izmir Kâtip Çelebi University
Life
Izmir Kâtip Çelebi University
Building similarity graph...
Analyzing shared references across papers
Loading...
Kiris et al. (Wed,) reported a other. Anesthesia type during TAVI was not independently associated with mortality or MACCE after adjusting for baseline differences, despite an initial unadjusted advantage for local anesthesia (WR 1.79).
synapsesocial.com/papers/69d0aefd659487ece0fa4dec — DOI: https://doi.org/10.3390/life16040584
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: